News

Vietnam Investment Review3d

Ascletis Unveils ASC47 Weight Loss Drug Candidate

ASC47 is an adipose-targeted, once-monthly subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small ...
TipRanks on MSN3d

Ascletis Pharma’s ASC47 Shows Superior Efficacy in Obesity Treatment

Ascletis Pharma, Inc. ( ($HK:1672) ) just unveiled an update. Ascletis Pharma Inc. announced promising preclinical results for its ...